Daehwa Pharm. Delays Decision Deadline to Dec. 16
Daehwa Pharm. corrected a disclosure on Nov. 3, 2026, extending the deadline for deciding whether to designate it as an unfaithful disclosure corporation to Dec. 16.
Related stories
Advanced Info Service Reports Quarterly Revenue of 58.06 Billion Baht
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
Cosmo First Q2 Consolidated Revenue From Operations INR 13,878.6 Million
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
Cosmo First Reports Q2 Consolidated Net Profit of INR 985.8 Million
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
Advanced Info Service Reports Quarterly Profit of 13.50 Billion Baht
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
TSX Futures Slip as Oil Rebounds; US Midterms in Focus
Canadian stock futures slipped as oil rebounded, with US midterm elections in focus.
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
S&P/TSX Futures Fall 0.4% as Oil Rebounds and US Midterms Draw Focus
December S&P/TSX futures were down 0.4% at 5:41 a.m. ET as oil rebounded on dimmer hopes for a Middle East peace deal. Investors also watched the US midterm elections.
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC